380 related articles for article (PubMed ID: 15565109)
1. Application of comparative functional genomics to identify best-fit mouse models to study human cancer.
Lee JS; Chu IS; Mikaelyan A; Calvisi DF; Heo J; Reddy JK; Thorgeirsson SS
Nat Genet; 2004 Dec; 36(12):1306-11. PubMed ID: 15565109
[TBL] [Abstract][Full Text] [Related]
2. Comparative functional genomics for identifying models of human cancer.
Lee JS; Grisham JW; Thorgeirsson SS
Carcinogenesis; 2005 Jun; 26(6):1013-20. PubMed ID: 15677630
[TBL] [Abstract][Full Text] [Related]
3. Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.
Yim SY; Shim JJ; Shin JH; Jeong YS; Kang SH; Kim SB; Eun YG; Lee DJ; Conner EA; Factor VM; Moore DD; Johnson RL; Thorgeirsson SS; Lee JS
Mol Cancer Res; 2018 Nov; 16(11):1713-1723. PubMed ID: 30082483
[TBL] [Abstract][Full Text] [Related]
4. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
Schlaeger C; Longerich T; Schiller C; Bewerunge P; Mehrabi A; Toedt G; Kleeff J; Ehemann V; Eils R; Lichter P; Schirmacher P; Radlwimmer B
Hepatology; 2008 Feb; 47(2):511-20. PubMed ID: 18161050
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.
Meyer K; Lee JS; Dyck PA; Cao WQ; Rao MS; Thorgeirsson SS; Reddy JK
Carcinogenesis; 2003 May; 24(5):975-84. PubMed ID: 12771043
[TBL] [Abstract][Full Text] [Related]
6. Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas.
Okada H; Kimura MT; Tan D; Fujiwara K; Igarashi J; Makuuchi M; Hui AM; Tsurumaru M; Nagase H
Int J Oncol; 2005 Feb; 26(2):369-77. PubMed ID: 15645121
[TBL] [Abstract][Full Text] [Related]
7. [Comparative genomic classification of human hepatocellular carcinoma].
Kaposi-Novák P
Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
[TBL] [Abstract][Full Text] [Related]
8. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
9. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.
Calvisi DF; Simile MM; Ladu S; Pellegrino R; De Murtas V; Pinna F; Tomasi ML; Frau M; Virdis P; De Miglio MR; Muroni MR; Pascale RM; Feo F
Int J Cancer; 2007 Dec; 121(11):2410-20. PubMed ID: 17680562
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
Gougelet A; Sartor C; Senni N; Calderaro J; Fartoux L; Lequoy M; Wendum D; Talbot JN; Prignon A; Chalaye J; Imbeaud S; Zucman-Rossi J; Tordjmann T; Godard C; Bossard P; Rosmorduc O; Amaddeo G; Colnot S
Gastroenterology; 2019 Sep; 157(3):807-822. PubMed ID: 31194980
[TBL] [Abstract][Full Text] [Related]
11. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.
Kaposi-Novak P; Lee JS; Gòmez-Quiroz L; Coulouarn C; Factor VM; Thorgeirsson SS
J Clin Invest; 2006 Jun; 116(6):1582-95. PubMed ID: 16710476
[TBL] [Abstract][Full Text] [Related]
12. Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver.
Tilton SC; Gerwick LG; Hendricks JD; Rosato CS; Corley-Smith G; Givan SA; Bailey GS; Bayne CJ; Williams DE
Toxicol Sci; 2005 Dec; 88(2):319-30. PubMed ID: 16141433
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
Ikeguchi M; Hirooka Y
Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
[TBL] [Abstract][Full Text] [Related]
14. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C
Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
[TBL] [Abstract][Full Text] [Related]
15. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
Iizuka N; Oka M; Yamada-Okabe H; Hamada K; Nakayama H; Mori N; Tamesa T; Okada T; Takemoto N; Matoba K; Takashima M; Sakamoto K; Tangoku A; Miyamoto T; Uchimura S; Hamamoto Y
Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
[TBL] [Abstract][Full Text] [Related]
16. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
17. Genomic Profiling Reveals Unique Molecular Alterations in Hepatoblastomas and Adjacent Hepatocellular Carcinomas in B6C3F1 Mice.
Bhusari S; Pandiri AR; Nagai H; Wang Y; Foley J; Hong HH; Ton TV; DeVito M; Shockley KR; Peddada SD; Gerrish KE; Malarkey DE; Hooth MJ; Sills RC; Hoenerhoff MJ
Toxicol Pathol; 2015 Dec; 43(8):1114-26. PubMed ID: 26289556
[TBL] [Abstract][Full Text] [Related]
18. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
19. Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis.
Coulouarn C; Gomez-Quiroz LE; Lee JS; Kaposi-Novak P; Conner EA; Goldina TA; Onishchenko GE; Factor VM; Thorgeirsson SS
Hepatology; 2006 Oct; 44(4):1003-11. PubMed ID: 17006931
[TBL] [Abstract][Full Text] [Related]
20. Functional genomics of hepatocellular carcinoma.
Thorgeirsson SS; Lee JS; Grisham JW
Hepatology; 2006 Feb; 43(2 Suppl 1):S145-50. PubMed ID: 16447291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
